Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Figlin

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Oncogene|September 1, 1990
Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study GroupJ R Berenson, H Koga, J Yang, et al.
The Journal of Urology|January 27, 2000
Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomiesK H Tsui, O Shvarts, Z Barbaric, et al.
The Cancer Journal From Scientific American|February 11, 1998
Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patientsR Figlin, B Gitlitz, J Franklin, et al.
The Journal of Urology|January 27, 2000
Renal cell carcinoma: prognostic significance of incidentally detected tumorsK H Tsui, O Shvarts, R B Smith, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|March 1, 1996
Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapyA Belldegrun, C L Tso, R Kaboo, et al.
Clinical Nephrology|February 12, 2002
The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancerA Safaei, R Figlin, C K Hoh, et al.
American Journal of Clinical Oncology|October 1, 1985
Human alpha-lymphoblastoid interferon. A phase I study including pharmacokinetics and effects on hematologic stem cells (CFU-GMs)G Sarna, R Figlin, Y Bryson, et al.
Clinical Immunology and Immunopathology|August 1, 1994
Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivoG G Steger, W C Pierce, R Figlin, et al.
Cancer|December 1, 1996
An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patientsC Y Nishikubo, L A Kunkel, R Figlin, et al.
Cancer|October 1, 1994
In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transferR W Hathorn, C L Tso, R Kaboo, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Oncogene|September 1, 1990
Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study GroupJ R Berenson, H Koga, J Yang, et al.
The Journal of Urology|January 27, 2000
Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomiesK H Tsui, O Shvarts, Z Barbaric, et al.
The Cancer Journal From Scientific American|February 11, 1998
Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patientsR Figlin, B Gitlitz, J Franklin, et al.
The Journal of Urology|January 27, 2000
Renal cell carcinoma: prognostic significance of incidentally detected tumorsK H Tsui, O Shvarts, R B Smith, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|March 1, 1996
Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapyA Belldegrun, C L Tso, R Kaboo, et al.
Clinical Nephrology|February 12, 2002
The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancerA Safaei, R Figlin, C K Hoh, et al.
American Journal of Clinical Oncology|October 1, 1985
Human alpha-lymphoblastoid interferon. A phase I study including pharmacokinetics and effects on hematologic stem cells (CFU-GMs)G Sarna, R Figlin, Y Bryson, et al.
Clinical Immunology and Immunopathology|August 1, 1994
Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivoG G Steger, W C Pierce, R Figlin, et al.
Cancer|December 1, 1996
An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patientsC Y Nishikubo, L A Kunkel, R Figlin, et al.
Cancer|October 1, 1994
In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transferR W Hathorn, C L Tso, R Kaboo, et al.
Pageof 5